Human induced pluripotent stem cells (iPSCs) derived from human somatic cells can differentiate into a variety of ocular cells such as corneal epithelial cells and retinal pigment epithelium cells. These cells provide effective tools for ophthalmologic disease modeling and personal drug discovery as well as developing cell-based therapy. Learn more about stem cell in Ophthalmologic Diseases: https://www.creative-biolabs.com/stem-cell-therapy/ophthalmologic-diseases.htm
comments (0)
Copyright 2019 © P-tweets Refunds